These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 688216)

  • 1. Changing transplantation characteristics with serial in vivo passage of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1978 Oct; 38(10):3264-8. PubMed ID: 688216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherent changes in the in vivo growth characteristics of C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1980 Oct; 40(10):3495-3501. PubMed ID: 7438036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary tumor virus oncogenesis and tumor immunogenicity in three sublines of the C3H mouse.
    Vaage J; Medina D
    Cancer Res; 1978 Aug; 38(8):2443-7. PubMed ID: 208767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between tumor growth characteristics and preferential sites of growth.
    Vaage J
    J Natl Cancer Inst; 1984 May; 72(5):1199-203. PubMed ID: 6585595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of shared nonviral tumor-associated transplantation-type antigens among C3H/He mammary carcinomas.
    Vaage J
    Cancer Res; 1984 May; 44(5):1876-9. PubMed ID: 6201265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
    Vaage J; Agarwal S
    Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chemical carcinogen treatment on the immunogenicity of mouse mammary tumors arising from hyperplastic alveolar nodule outgrowth lines.
    Ruppert B; Wei W; Medina D; Heppner GH
    J Natl Cancer Inst; 1978 Oct; 61(4):1165-9. PubMed ID: 100605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology of spontaneous mammary carcinomas in mice: immunogenicity of mammary tumor virus-contaning tissues in mammary tumor virus-free C3H-2 hosts.
    Lavrin DH
    Cancer Res; 1970 Apr; 30(4):1156-62. PubMed ID: 4323351
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonspecific T-cell reactivity in mice bearing autochthonous tumors or early-generation transplanted spontaneous mammary tumors.
    Parthenais E; Haskill S
    J Natl Cancer Inst; 1979 Jun; 62(6):1569-74. PubMed ID: 312353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A time factor in the success or failure of immune rejection of transplanted tumors.
    Vaage J
    Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse.
    Hosokawa M; Orsini F; Mihich E
    Cancer Res; 1975 Oct; 35(10):2657-62. PubMed ID: 1157040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum therapy for radiation-induced impairment of immune resistance to metastasis.
    Vaage J; Agarwal S
    Cancer Res; 1977 Oct; 37(10):3556-60. PubMed ID: 908007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of spontaneous mammary carcinomas in mice. 3. Immunogenicity of C3H preneoplastic hyperplastic alveolar nodules in C3Hf hosts.
    Lavrin DH; Blair PB; Weiss DW
    Cancer Res; 1966 Feb; 26(2):293-304. PubMed ID: 5903180
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated growth of mammary tumor cells in normal and athymic mice after treatment in vitro with dexamethasone.
    Gillette RW; Wunderlich DA
    Cancer Res; 1978 Oct; 38(10):3146-9. PubMed ID: 80260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of tumor-specific immunity against antigens unrelated to the mammary tumor virus in spontaneous mammary adenocarcinomas.
    Morton DL; Miller GF; Wood DA
    J Natl Cancer Inst; 1969 Feb; 42(2):289-301. PubMed ID: 4303881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.